Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Clinical trial NCT00028912 · COMPLETED
Trial details
- NCT number
- NCT00028912
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.